Rua Bioscience (NZSE:RUA) ROCE % : -32.83% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Rua Bioscience ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Rua Bioscience's annualized ROCE % for the quarter that ended in Dec. 2023 was -32.83%.

Rua Bioscience ROCE % Historical Data

The historical data trend for Rua Bioscience's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rua Bioscience ROCE % Chart

Rua Bioscience Annual Data

Trend

Jun21

Jun22

Jun23

ROCE %

-20.77

-24.71

-53.17

Rua Bioscience Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial			-26.27	-25.79	-26.38	-79.47	-32.83

Rua Bioscience ROCE % Calculation

Rua Bioscience's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	-13.001	/	( ( (33.574 - 4.859)	+	(20.951 - 0.762) )	/ 2 )
	=	-13.001	/	( (28.715	+	20.189)	/ 2 )
	=	-13.001	/	24.452
	=	-53.17 %

Rua Bioscience's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-4.89	/	( ( (20.951 - 0.762)	+	(10.031 - 0.431) )	/ 2 )
	=	-4.89	/	( ( 20.189	+	9.6 )	/ 2 )
	=	-4.89	/	14.8945
	=	-32.83 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Rua Bioscience (NZSE:RUA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Rua Bioscience ROCE % Related Terms

Thank you for viewing the detailed overview of Rua Bioscience's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rua Bioscience (NZSE:RUA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rua Bioscience Ltd (NZSE:RUA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Commerce Place, Awapuni, Gisborne, NZL, 4071

Website

https://www.ruabio.com

Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Germany and New Zealand.

Rua Bioscience (NZSE:RUA) Headlines

No Headlines